Skip to main content
BridgeBio Pharma, Inc. logo

BridgeBio Pharma, Inc. — Investor Relations & Filings

Ticker · BBIO ISIN · US10806X1028 LEI · 54930028YG89VTY2J114 US Manufacturing
Filings indexed 740 across all filing types
Latest filing 2023-05-04 Interim / Quarterly Rep…
Country US United States of America
Listing US BBIO

About BridgeBio Pharma, Inc.

https://bridgebio.com/

BridgeBio Pharma, Inc. is a biotechnology company that discovers, creates, tests, and delivers transformative medicines for patients with genetic diseases and cancers with clear genetic drivers. The company's mission is to bridge the gap between advancements in genetic science and patients with unmet medical needs. It focuses on translating early scientific discoveries into patient solutions as quickly and safely as possible through a novel corporate model that combines a focus on drug products with an efficient development engine.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report Q1 2023
2023-05-04 English
8-K
Regulatory Filings
2023-05-04 English
Regulatory Filings 2023
Regulatory Filings
2023-05-03 English
ARS
Annual Report
2023-04-28 English
DEFA14A
Regulatory Filings
2023-04-28 English
DEF 14A
Proxy Solicitation & Information Statement
2023-04-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.